Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents?
- 1 January 1998
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 6 (2) , 83-88
- https://doi.org/10.1023/A:1008870700908
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Selective Inhibition of Factor Xa Is More Efficient Than Factor VIIa–Tissue Factor Complex Blockade at Facilitating Coronary Thrombolysis in the Canine ModelJournal of the American College of Cardiology, 1996
- Intramyocardial Injections and Protection Against Myocardial IschemiaCirculation, 1996
- Adventitia as a target for intravascular local drug delivery.Heart, 1996
- Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activatorAmerican Heart Journal, 1996
- Anticoagulant Effects of Low-Molecular-Weight Heparin following Thrombolytic Therapy in Acute Myocardial Infarction: A Dose-Finding StudyPathophysiology of Haemostasis and Thrombosis, 1996
- Treatment of exudative fibririous pericarditis with intrapericardial urokinaseThe Lancet, 1994
- Sotalol Controlled-Release Systems for Arrhythmias: In Vitro Characterization, in Vivo Drug Disposition, and Electrophysiologic EffectsJournal of Pharmaceutical Sciences, 1994
- Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine arteryJournal of the American College of Cardiology, 1990
- Use of streptokinase to aid in drainage of postoperative pericardial effusion.Heart, 1989
- Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.Circulation Research, 1985